Chile vs South-Eastern Asia: Proportion of the target population who received the final dose of
Chile
87.0%
in 2024
South-Eastern Asia
51.0%
in 2024
Chile rank
16th
South-Eastern Asia rank
13th
Proportion of the target population who received the final dose of over time
- Chile
- South-Eastern Asia
How they compare
Chile currently reports 87.0% against 51.0% in South-Eastern Asia, a difference of 36.0%.
That makes Chile's figure about 1.7 times South-Eastern Asia's.
Across all 10 years both countries report, Chile has been ahead every year.
Chile ranks 16th and South-Eastern Asia ranks 13th of 107 countries.
Chile has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chile | South-Eastern Asia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.8% | 8.4% | 69.4% | Chile |
| 2020s | 74.6% | 19.2% | 55.4% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Chile or South-Eastern Asia?
- Chile, at 87.0% against 51.0% in South-Eastern Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Chile and South-Eastern Asia?
- 36.0%, with Chile ahead.
- How many years of comparable data are there for Chile and South-Eastern Asia?
- 10 years are reported by both, from 2015 to 2024.
- How do Chile and South-Eastern Asia rank globally for proportion of the target population who received the final dose of?
- Chile ranks 16th and South-Eastern Asia ranks 13th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.